Morita-Baylis-Hillman adduct 2-(3-hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) modulates the inflammatory process during LPS-induced acute lung injury

References

• Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell [Internet]. 2010;140(6):771–776.
   Google Scholar
• Fullerton JN, Gilroy DW. Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016;15(8):551–567.
   PubMed Web of Science ®Google Scholar
• Kameritsch P, Renkawitz J. Principles of leukocyte migration strategies. Trends Cell Biol. 2020;30(10):818–832.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428–435.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Zemans RL, Zimmerman GA, et al. Acute respiratory distress syndrome. Nat Rev Dis Prim. 2018;5:18.
   Web of Science ®Google Scholar
• Goodman RB, Pugin J, Lee JS, et al. Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 2003;14(6):523–535.
   PubMed Web of Science ®Google Scholar
• Butt Y, Kurdowska A, Allen TC. Acute lung injury: a clinical and molecular review. Arch Pathol Lab Med. 2016;140(4):345–350.
   PubMed Web of Science ®Google Scholar
• de França JS, de Sales-Neto JM, Carvalho DCM, et al. Morita-Baylis-Hillman adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN) modulates inflammatory process in vitro and in vivo. Inflammation. 2021;44(3):899–907.
   PubMed Web of Science ®Google Scholar
• Lima CG, Faheina-Martins GV, Bomfim CCB, et al. Synthesis, cytotoxic activity on leukemia cell lines and quantitative Structure-Activity relationships (QSAR) studies of Morita-Baylis-Hillman adducts. Med Chem. 2016;12(7):602–612.
   PubMed Web of Science ®Google Scholar
• Mokra D, Mikolka P, Kosutova P, et al. Corticosteroids in acute lung injury: the dilemma continues. IJMS. 2019;20(19):4765.
   Google Scholar
• do Nascimento Xavier BM, Ferreira LAMP, Ferreira LKDP, et al. MHTP, a synthetic tetratetrahydroisoquinoline alkaloid, attenuates lipopolysaccharide-induced acute lung injury via p38MAPK/p65NF-κB signaling pathway-TLR4 dependent. Inflamm Res. 2019;68(12):1061–1070.
   PubMed Web of Science ®Google Scholar
• Wei F, Wen S, Wu H, et al. Partial liquid ventilation–induced mild hypothermia improves the lung function and alleviates the inflammatory response during acute respiratory distress syndrome in canines. Biomed Pharmacother. 2019;118:109344.
   PubMed Web of Science ®Google Scholar
• Moraes TJ, Zurawska JH, Downey GP. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol. 2006;13(1):21–27.
   PubMed Web of Science ®Google Scholar
• Kandasamy R, Park SJ, Boyapalle S, et al. Isatin down-regulates expression of atrial natriuretic peptide receptor a and inhibits airway inflammation in a mouse model of allergic asthma. Int Immunopharmacol. 2010;10(2):218–225.
   PubMed Web of Science ®Google Scholar
• Park WY, Goodman RB, Steinberg KP, et al. Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1896–1903.
   PubMed Web of Science ®Google Scholar
• Faheina-Martins GV, Leite JA, Dantas BB, et al. Morita-Baylis-Hillman adducts display anti-Inflammatory effects by modulating inflammatory mediator expression in RAW264.7 cells. Mediators Inflamm [Internet]. 2017;2017:1–9.
   Web of Science ®Google Scholar
• Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med. 2006;27(4):337–349.
   PubMed Web of Science ®Google Scholar
• Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol. 2008; 295(3):L379–399.
   PubMed Web of Science ®Google Scholar
• Lee C-H, Choi EY. Macrophages and inflammation. J Rheum Dis. 2018;25(1):11.
   Google Scholar
• Biswas SK, Chittezhath M, Shalova IN, et al. Macrophage polarization and plasticity in health and disease. Immunol Res. 2012;53(1-3):11–24.
   PubMed Web of Science ®Google Scholar
• He W, Kapate N, Shields CW, et al. Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases. Adv Drug Deliv Rev. 2020;165-166:15–40.
   PubMed Web of Science ®Google Scholar
• Lacerda LM. Avaliação Da Atividade Anti-Inflamatória E Antitumoral De Novos Adutos Da Reação De Morita- Baylis-Hillman2017.
   Google Scholar
• Matheus ME, Violante F de A, Garden SJ, et al. Isatins inhibit cyclooxygenase-2 and inducible nitric oxide synthase in a mouse macrophage cell line. Eur J Pharmacol. 2007;556(1-3):200–206.
   PubMed Web of Science ®Google Scholar
• Rossol M, Heine H, Meusch U, et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. 2011;31(5):379–446.
   PubMed Web of Science ®Google Scholar
• Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008;42(2):145–151.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Gay S. TLRs and chronic inflammation. Int J Biochem Cell Biol. 2010;42(4):495–505.
   PubMed Web of Science ®Google Scholar
• Kiechl S, Lorenz E, Reindl M, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med. 2002;347(3):185–192.
   PubMed Web of Science ®Google Scholar
• Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J. 2004;25(16):1447–1453.
   PubMed Web of Science ®Google Scholar
• Fukata M, Shang L, Santaolalla R, et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis. 2011;17(7):1464–1473.
   PubMed Web of Science ®Google Scholar
• Gao W, Xiong Y, Li Q, et al. Inhibition of toll-like receptor signaling as a promising therapy for inflammatory diseases: a journey from molecular to nano therapeutics. Front Physiol. 2017;8:508.
   PubMed Web of Science ®Google Scholar
• Marzio R, Jirillo E, Ransijn A, et al. Expression and function of the early activation antigen CD69 in murine macrophages. J Leukoc Biol. 1997;62(3):349–355.
   PubMed Web of Science ®Google Scholar
• Cibrián D, Sánchez-Madrid F. CD69: from activation marker to metabolic gatekeeper. Eur J Immunol. 2017;47(6):946–953.
   PubMed Web of Science ®Google Scholar
• Murata K, Inami M, Hasegawa A, et al. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol. 2003;15(8):987–992.
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Kasuya Y, Kuroda F, et al. Attenuation of lung inflammation and fibrosis in CD69-deficient mice after intratracheal bleomycin. Respir Res. 2011;12(1):131–110.
   PubMed Web of Science ®Google Scholar
• Ishizaki S, Kasuya Y, Kuroda F, et al. Role of CD69 in acute lung injury. Life Sci. 2012;90(17-18):657–665.
   PubMed Web of Science ®Google Scholar
• Wang HY, Dai Y, Wang JL, et al. Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma. J Zhejiang Univ Sci B. 2015;16(7):622–631.
   PubMed Web of Science ®Google Scholar
• Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem. 1995;270(28):16483–16486.
   PubMed Web of Science ®Google Scholar
• Castellanos MC, Muñoz C, Montoya MC, et al. Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1. J Immunol. 1997;159(11):5463–5473.
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Gibson TB, et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001;22(2):153–183.
   PubMed Web of Science ®Google Scholar
• Gao W, Zhang L, Wang X, et al. The combination of indirubin and isatin attenuates dextran sodium sulfate induced ulcerative colitis in mice. Biochem Cell Biol. 2018;96(5):636–645.
   PubMedGoogle Scholar
• Zeeshan S, Naveed M, Khan A, et al. N-Pyrazoloyl and N-thiopheneacetyl hydrazone of isatin exhibited potent anti-inflammatory and anti-nociceptive properties through suppression of NF-κB, MAPK and oxidative stress signaling in animal models of inflammation. Inflamm Res. 2019;68(7):613–632.
   PubMed Web of Science ®Google Scholar